GALT   $2.75  -1.79% Market Closed After Close 2.75 0.0

Galectin Therapeutics Inc.
Total Cash 25.60M
totalCashPerShare 0.411
EBITDA
Total Debt 93.47M
quickRatio 1.751
currentRatio 1.867
Total Revenue
debtToEquity
Revenue/Share
ROA -1.03868
ROE
grossProfits
freeCashflow -20.36M
operatingCashflow -32.78M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 232.32M
forwardPE -1.5505953
floatShares 43.10M
sharesOutstanding 62.28M
sharesShort 5.46M
sharesShortPriorMonth 5.26M
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.31%
heldPercentInstitutions 0.15%
Short Ratio help_outline 42.54%
shortPercentOfFloat 0.18%
impliedSharesOutstanding
bookValue -1.355
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -48.03M
trailingEps -0.78%
forwardEps -1.68%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.2 3Q 2024
institutionsCount 95
lastUpdated Nov. 6, 2024, 5:23 p.m.